(Q42545814)

2 November 2017

title

Effects of L-dopa and bromocriptine on haloperidol-induced motor deficits in mice (English)

1 reference

2 November 2017

Kobayashi T

1

1 reference

2 November 2017

Araki T

2

1 reference

2 November 2017

Itoyama Y

3

1 reference

2 November 2017

Takeshita M

4

1 reference

2 November 2017

Ohta T

5

1 reference

2 November 2017

Oshima Y

6

1 reference

2 November 2017

language of work or name

English

0 references

publication date

1 January 1997

1 reference

2 November 2017

1 reference

2 November 2017

volume

61

1 reference

2 November 2017

issue

26

1 reference

2 November 2017

page(s)

2529-2538

1 reference

Relationship of neuroleptic drug effects at brain dopamine, serotonin, alpha-adrenergic, and histamine receptors to clinical potency

2 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2901007-2

Dopamine in the basal ganglia. Its role and therapeutic implications (including the clinical use of L-DOPA).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2901007-2

The catalepsy test: its ups and downs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2901007-2

International symposium on early dopamine agonist therapy of Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2901007-2

Dopamine agonist treatment of fluctuating parkinsonism. D-2 (controlled-release MK-458) vs combined D-1 and D-2 (pergolide)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2901007-2

MPTP-induced parkinsonian model in mice: biochemistry, pharmacology and behavior.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2901007-2

Opposite effects of NMDA and AMPA receptor blockade on catalepsy induced by dopamine receptor antagonists

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2901007-2

The effect of L-dopa on neuroleptic-induced catalepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2901007-2

Anticataleptic effects of the N-methyl-D-aspartate antagonist MK-801 in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2901007-2

Synergistic effects between D-1 and D-2 dopamine antagonists on catalepsy in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2901007-2

The contribution of the different binding sites of the N-methyl-D-aspartate (NMDA) receptor to the expression of behavior

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2901007-2

Evaluation of a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated C57 black mouse model for parkinsonism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2901007-2

1-Methyl-1,2,3,4-tetrahydroisoquinoline, decreasing in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated mouse, prevents parkinsonism-like behavior abnormalities.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2901007-2

10.1016/S0024-3205(97)01007-2

7 January 2021

Identifiers

DOI

1 reference

release_3nfopbsx4vebpcchty3p56mnzm

2 November 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/3nfopbsx4vebpcchty3p56mnzm

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference